
Mydekla 60 Tablet
Marketer
Mylan Pharmaceuticals Pvt Ltd - A Viatris Company
Salt Composition
Daclatasvir (60mg)
Overview Mydekla 60 Tablet
Hepcinat 60mg tablets are an antiviral drug indicated for use in conjunction with other therapies to manage chronic hepatitis C (HCV) infection. Dosage and treatment length should strictly follow your physician's instructions. This medication may be taken with or without food, ideally at the same time daily. Consistent dosing is crucial; complete the prescribed regimen even with symptom improvement. If a dose is missed, take it immediately; however, if the next dose is imminent, omit the missed one and resume your usual schedule. Never double the dose. Compared to similar treatments, it exhibits a lower incidence of side effects such as tiredness, headaches, nausea, sleep disturbances, and low red blood cell counts. Report persistent side effects to your doctor. Pregnant women, those planning pregnancy, and breastfeeding mothers should seek medical advice before use.
Uses of Mydekla 60 Tablet
Persistent infection with the hepatitis C virus (HCV)
Major Benefits of Mydekla 60 Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mydekla 60 Tablet can be consumed with or without food, however, consistent timing is recommended.
Common Side effects of Mydekla 60 Tablet:
- Fatigue
- Headache
- Nausea
- Insomnia (difficulty in sleeping)
- Anemia (low number of red blood cells)
How to use Mydekla 60 Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mydekla 60 Tablets can be consumed with or without food, although consistent timing is recommended.
How Mydekla 60 Tablet works:
Hepatitis C antiviral Mydekla 60mg tablets reduce the viral load, ultimately clearing the virus from the bloodstream.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of Mydekla 60 Tablet and alcohol is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Mydekla 60 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any possible risks prior to prescription. Seek medical advice before taking this medication.
Breast feedingSAFE IF PRESCRIBED
The use of Mydekla 60 Tablet while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
Mydekla 60 Tablet's effect on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Mydekla 60 Tablets can be administered to patients with kidney disease without altering the dosage.
LiverSAFE IF PRESCRIBED
Mydekla 60 mg tablets pose no safety concerns for patients with hepatic impairment; no dosage modification is necessary.
What if you forget to take Mydekla 60 Tablet :
Should you forget a Mydekla 60 Tablet dose, administer it at your earliest convenience. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual medication regimen.
Facts to Know About Mydekla 60 Tablet
Label | Value |
---|---|
Chemical Category | Valine-based compounds |
Developing Habits | No. |
Treatment Category | Antimicrobials |
Actions | Hepatitis C direct-acting antiviral |